U.S. health officials are conducting an analysis on whether marijuana should be reclassified under federal law.
The DEA has asked the Food and Drug Administration to carry out a review of marijuana’s status as a Schedule I drug, a FDA official revealed during a congressional hearing on Friday.
The FDA will evaluate whether marijuana still meets the Schedule I criteria, which considers cannabis to be highly dangerous with no medical use.
Full article here.
Support Postcards for a Cause – a postcard campaign to President Obama and Eric Holder to encourage the descheduling of marijuana.
Read More »